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Abstract.
 
Objectives
 
:
 
 
 
This article is to study the role of G
 
1
 
/S regulators in differentiation
of pluripotent embryonic cells. 
 
Materials and methods
 
: We established a P19 embryonal
carcinoma cell-based experimental system, which proﬁts from two similar differentiation
protocols producing endodermal or neuroectodermal lineages. The levels, mutual inter-
actions, activities, and localization of G
 
1
 
/S regulators were analysed with respect to growth
and differentiation parameters of the cells. 
 
Results and Conclusions
 
: We demonstrate
that proliferation parameters of differentiating cells correlate with the activity and structure
of cyclin A/E–CDK2 but not of cyclin D–CDK4/6–p27 complexes. In an exponentially
growing P19 cell population, the cyclin D1–CDK4 complex is detected, which is replaced
by cyclin D2/3–CDK4/6–p27 complex following density arrest. During endodermal
differentiation kinase-inactive cyclin D2/D3–CDK4–p27 complexes are formed. Neural
differentiation speciﬁcally induces cyclin D1 at the expense of cyclin D3 and results
in predominant formation of cyclin D1/D2–CDK4–p27 complexes. Differentiation is
accompanied by cytoplasmic accumulation of cyclin Ds and CDK4/6, which in neural
cells are associated with neural outgrowths. Most phenomena found here can be reproduced
in mouse embryonic stem cells. In summary, our data demonstrate (i) that individual
cyclin D isoforms are utilized in cells lineage speciﬁcally, (ii) that fundamental difference
in the function of CDK4 and CDK6 exists, and (iii) that cyclin D–CDK4/6 complexes
function in the cytoplasm of differentiated cells. Our study unravels another level of
complexity in G
 
1
 
/S transition-regulating machinery in early embryonic cells.
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INTRODUCTION
 
During development of multi-cellular organisms, cell lineages become speciﬁed, cells acquire
unique cell fates, and they differentiate. Differentiation processes proceed in a balanced concerted
way, with cell proliferation and cell death maintaining homeostasis of the entire organism. At
least some differentiation processes can be effectively mimicked 
 
in vitro
 
 using pluripotent
embryonic stem (ES) and embryonal carcinoma (EC) cells, which have their physiological
 
in vivo
 
 counterparts in cells of pre-implantation embryos (Andrews 
 
et al
 
. 2001; Smith 2001).
Cyclin-dependent kinases (CDKs), their activating and inhibiting partners – cyclins and
CDK inhibitors (CKIs), are well recognized as essential regulators of cell proliferation. Their
interactions, activities and functions as related to regulation of both progression of the cell cycle
and maintenance of the quiescent state are well established (for reviews, see Sherr 1995; Sherr
& Roberts 1999). Yet, irrespective of whether the cells reside in a developing embryo or in an
adult organism, expression of individual cell cycle regulators of G
 
1
 
 and S phases is signiﬁcantly
diverse, with individual cell types employing speciﬁc G
 
1
 
/S cell cycle regulators to guarantee a
balance between proliferation, quiescence, and/or maintenance of differentiation (for reviews,
see Gao & Zelenka 1997; Nakayama & Nakayama 1998). In this study, mouse embryonal
carcinoma cells (line P19) have been employed to address the question of how such molecular
diversiﬁcation develops during the earliest steps of differentiation that take place in the early
embryo.
Up until now, several 
 
in vitro
 
 studies have been undertaken with the aim of understanding
the role of cell cycle regulators in early differentiation; however, their results are not completely
congruent (Savatier 
 
et al
 
. 1995; Gill 
 
et al
 
. 1998; Baldassarre 
 
et al
 
. 1999; Li 
 
et al
 
. 1999;
Watanabe 
 
et al
 
. 1999; Baldassarre 
 
et al
 
. 2000; Glozak & Rogers 2001; Preclikova 
 
et al
 
. 2002;
Bryja 
 
et al
 
. 2004b; Bryja 
 
et al
 
. 2005). Still, as culture systems (monolayer versus three-
dimensional), differentiation-inducing strategy/compounds, timing, cell density and other factors
vary from study to study, controversies are likely to some extent, due to differences in experimental
setup. Here, to overcome such limitations, we have introduced a simple experimental design that
uses P19 EC cells, which proﬁts from two different retinoic acid (RA)-based differentiation
protocols, that in 4 days produce homogenous populations of primitive endodermal and primitive
neuroectodermal cells, respectively. Importantly, it is also inherent to this setup that differentiation-
associated changes to cell population growth, measured by cell density, DNA synthesis and
distribution in cell cycle phases, are similar in both endodermal and ectodermal pathways.
Experiments employing this design have led to the following ﬁndings: while cyclin A/E-CDK2
activity correlate with cell population growth parameters independently of differentiation status
of cells, differences in cell fate are associated with existence of several types of molecular complex
formed by D-type cyclins, CDK4, or CDK6 and p27. We assume that this molecular diversity
mirrors distinct roles of (i) CDK4 and CDK6, and (ii) individual D-type cyclins, and that these
molecules play a part in cell fate speciﬁcation.
 
MATERIALS AND METHODS
 
Cell culture
 
P19 EC cells (ATCC no. CRL-1825) were cultured on gelatinized tissue dishes in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) containing 10% foetal calf serum, 0.05 m
 
m
 
 
 
β
 
-mercaptoethanol, 
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100 IU/mL penicillin, and 0.1 mg/mL streptomycin. Mouse ES cells (line 10) and conditions for
their culture have been described previously (Bryja 
 
et al
 
. 2004b). To initiate differentiation, cells
(5 
 
×
 
 10
 
3
 
 per cm
 
2
 
) were seeded onto gelatinized tissue culture dishes 12 h before application of
experimental conditions. The cells were then cultured for 48 h in DMEM containing 10% foetal
calf serum or in DMEM/F-12 (1 : 1) media supplemented with insulin–transferrin–selenium
supplement (ITS) and antibiotics (further referred to as ITS medium) (all Gibco-Invitrogen,
Carlsbad, CA, USA) either in the presence or absence of 0.5 
 
μ
 
m
 
 RA (Sigma-Aldrich, St. Louis,
MO, USA). RA was then removed from the respective cultures and all cell populations were
grown for another 48 h until the experiments were ended at 96 h (see Fig. 1a, for the schematic
diagram of culture conditions).
Figure 1. Characterization of differentiation protocols. (a) FCS, foetal calf serum; ITS, insulin-, transferrin- and
selenium-supplemented medium (see the Material and Methods section); RA, retinoic acid. (b) The morphology and
density of cells during the culture conditions outlined in (a) was monitored by phase contrast microscopy at 48 and 96 h.
(c) Cells were differentiated according to protocols outlined in (a), and following 96 h of culture levels of cytokeratin
endo A (TROMA-1), E-cadherin, βIII-tubulin and Oct-4 were determined by Western blotting. Total protein visualized
using amidoblack staining is shown to demonstrate equal protein loading. (d) Following 96 h of culture, cells were ﬁxed
and stained for endodermal markers TROMA-1 (S and SR cells) and/or neural markers βIII-tubulin and N-CAM (IR
cells). 
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Cell population growth rate
 
Increases in absolute cell number and total cell protein were used as a measure of cell population
growth. Total cell number of P19 cells growing and/or differentiating on 6-well plates, according
to protocols described in Fig. 1a, were determined using a haemocytometer. Total cell protein
was determined as follows. Cells on culture dishes were washed twice with phosphate-buffered
saline (PBS; pH 7.2) and were lysed in 100 m
 
m
 
 Tris-HCl (pH 6.8) buffer containing 20%
glycerol and 1% sodium dodecyl sulfate (SDS). Protein concentrations, determined using a DC
protein assay kit (Bio-Rad, Hercules, CA, USA), were used to calculate total amount of protein
per dish.
 
Analysis of cell cycle distribution and DNA synthesis
 
For analysis of DNA synthesis, cells were labelled with 10 
 
μ
 
m
 
 5-bromo-2
 
′
 
-deoxyuridine (BrdU)
for 60 min, under standard culture conditions (37 
 
°
 
C, 5% CO
 
2
 
, 95% humidity). After labelling,
cells were trypsinized then ﬁxed in 70% ethanol at 4 
 
°
 
C overnight. Cell cycle distribution and
proportion of BrdU-positive cells were quantiﬁed using ﬂow cytometry (argon ion laser, 488 nm
excitation, FACSCalibur – Becton Dickinson, San Jose, CA, USA) essentially as described
previously (Bryja 
 
et al
 
. 2004b).
 
Real-time RT-PCR
 
Levels of mRNA for p27
 
Kip1
 
, cyclin D1, cyclin D2 and cyclin D3 were determined by real-
time quantitative RT-PCR using TaqMan
 
®
 
 Gene Expression Assays (Mm00438167_g1,
Mm00432359_m1, Mm00438071_m1, Mm01612362_m1, respectively; Applied Biosystems,
Foster City, CA, USA). Total RNA was isolated from cells using the RNeasy mini kit (Qiagen,
Valencia, CA, USA). Ampliﬁcation of the samples (200 ng of total RNA per reaction) was
carried out in duplicate, using QuantiTect Probe RT-PCR kit (Qiagen) according to manufacturer’s
instructions. All ampliﬁcations were run on a Rotor-Gene™ thermal cycler (Corbett Research,
Sydney, Australia), using the following program: reverse transcription at 50 
 
°
 
C for 30 min,
initial activation step at 95 
 
°
 
C for 15 min, followed by 40 cycles at 94 
 
°
 
C for 15 s and 60 
 
°
 
C
for 60 s. Gene expression for each sample was expressed in terms of the threshold cycle (C
 
t
 
)
normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (
 
Δ
 
C
 
t
 
), as determined using
TaqMan
 
®
 
 Rodent GAPDH Control Reagents (Applied Biosystems). 
 
Δ
 
C
 
t
 
 values were then
compared between control samples (cells grown for 48 h) and samples from treated cells, to
calculate 
 
ΔΔ
 
C
 
t
 
 [
 
Δ
 
C
 
t
 
 (control) – 
 
Δ
 
C
 
t (test sample)]. Final comparison of transcript ratios between
samples is given as 2–ΔΔCt (Livak & Schmittgen 2001).
Western blot analysis
Cells on culture dishes were washed twice with PBS (pH 7.2), lysed in 100 mm Tris-HCl
(pH 6.8) containing 20% glycerol and 1% SDS, and were analysed by SDS-polyacrylamide gel
electrophoresis (PAGE) as described previously (Bryja et al. 2004b). Antibodies used were as
follows: mouse monoclonal antibody to cyclin D1 (sc-450), rabbit polyclonal antibodies to
CDK6 (sc-177), cyclin E (sc-481), poly(ADP-ribose) polymerase (PARP) (sc-7150) and Oct-4
(sc-9081), and goat polyclonal antibodies to CDK2 (sc-163-G), CDK4 (sc-601-G), and lamin B
(sc-6217) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA); mouse
monoclonal antibody to mouse p27 (K25020) was purchased from Transduction Laboratories
(Lexington, KY, USA); mouse monoclonal antibodies speciﬁcally recognizing cyclin A (Ab-1,
E23) and cyclin D2 (Ab-4, DCS-3.1 + DCS-5.2) (Bartkova et al. 1995) were purchased from
Neomarkers (Fremont, CA, USA); mouse monoclonal antibody speciﬁcally recognizing part of
the C-terminal of human cyclin D3, which cross-reacts with the mouse homologue (DCS-22)Cyclin D/CDK complexes in differentiation 879
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(Bartkova et al. 1996), was generously provided by Dr. Jiri Lukas (Danish Cancer Society,
Copenhagen, Denmark). Mouse monoclonal antibody against human neuron-speciﬁc class III
β-tubulin isotype, which cross-reacts with the mouse homologue (TU-20) was generously
provided by Dr. Pavel Draber (Institute of Molecular Genetics, Prague, Czech Republic). The
TROMA-1 hybridoma developed by Drs. P. Brulet and R. Kemler was obtained from the
Developmental Studies Hybridoma Bank, developed under the auspices of the National Institute
of Child Health and Development, and was maintained by the University of Iowa, Department
of Biological Sciences (Iowa City, IA, USA). After immunodetection, each membrane was
stained using amidoblack to conﬁrm equal protein loading.
Immunoprecipitation and kinase assays
For these assays, cells were extracted in ice-cold lysis buffer for 30 min [50 mm Tris-HCl
(pH 7.4), 150 mm sodium chloride, 0.5% Nonidet P-40, 1 mm ethylenediaminetetraacetic acid,
0.1 mm dithiothreitol, 50 mm sodium ﬂuoride, 8 mm β-glycerophosphate, 100 mm phenylmethyl-
sulphonyl ﬂuoride (PMSF), 1 μg/mL leupeptin, 1 μg/mL aprotinin, 10 μg/mL soybean trypsin
inhibitor, 10 μg/mL tosylphenylalanine chloromethane], and further processed essentially
as described previously (Bryja et al. 2004b). Brieﬂy, extracts were cleared by centrifugation at
15 000 g for 5 min at 4 °C and were stored at –80 °C until use. After thawing, protein concentra-
tions were determined using a DC protein assay kit (Bio-Rad). Extracts were incubated with
appropriate antibodies for 1 h, on ice. The following antibodies were used: sc-601-G against CDK4,
sc-163-G against CDK2, sc-177 against CDK6, sc-751 against cyclin A, and sc-481 against
cyclin E (all purchased from Santa Cruz Biotechnology). Immunoprecipitates were collected on
Protein G agarose beads by overnight rotation, washed four times with lysis buffer, re-suspended
in 2× Laemmli sample buffer, and were subjected to SDS-PAGE followed by Western blot
analysis. To control for speciﬁcity of the immunoprecipitation reaction, the control sample
containing only cell lysate and G protein-coupled beads, but no antibody, was included in each
set of immunoprecipitated samples (no antibody control). For kinase assays, immunoprecipitates
were prepared as above, except that the last two washes were performed using kinase assay
buffer [50 mm N-(2-hydroxyethyl) piperazine-N′-(2-ethanesulfonic) acid (HEPES), pH 7.5; 10 mm
MgCl2; 10 mm MnCl2; 8 mm β-glycerophosphate; 1 mm dithiothreitol]. For CDK2, kinase reac-
tions were carried out for 30 min at 37 °C in a total volume of 25 μL in kinase assay buffer sup-
plemented with 100 μg/mL histone H1 (type III-S) and 40 μCi/mL [32P]ATP. For CDK4, kinase
reactions were carried out for 30 min at 30 °C in a total volume of 25 μL in kinase assay buffer
supplemented with 160 μg/mL GST-pRb (type III-S) and 40 μCi/mL [32P]ATP. Reactions were
terminated by addition of 2× Laemmli sample buffer and each reaction mix was subjected to
SDS-PAGE and autoradiography. Two controls complemented each set of kinase reactions: no
antibody control and no substrate control. When required, intensities of signals were assessed
by densitometry using Intelligent Quantiﬁer software (BioImage, Ann Arbor, MI, USA).
Isolation of nuclear and cytoplasmic fractions
Cells were washed in PBS and dry frozen at –70 °C for further use. Following freezing, cells
were scraped in TKM buffer (50 mm Tris-HCl, pH 7.4, 5 mm MgCl2; 25 mm KCl; 100 mm
PMSF; 1 μg/mL leupeptin; 1 μg/mL aprotinin; 10 μg/mL soybean trypsin inhibitor; 10 μg/mL
tosylphenylalanine chloromethane), sonicated (10 s, 25 W), and fractionated by centrifugation
(10 min, 1000 g, 4 °C). When necessary, the supernatant, representing the cytoplasmic fraction,
was precipitated using trichloroacetic acid. Both pellet and precipitate were then dissolved in
100 mm Tris-HCl (pH 6.8) containing 20% glycerol and 1% SDS. Protein in each fraction was
quantiﬁed, and equal amounts of total protein were analysed by Western blotting.880 V . Bryja et al.
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Immunocytochemistry and confocal microscopy
Expression of differentiation markers and subcellular localization of cyclins and CDKs were
determined by indirect immunoﬂuorescence using the following antibodies: rat monoclonal
antibody to mouse endoderm-speciﬁc cytokeratin endo A (TROMA-I, Developmental Studies
Hybridoma Bank, University of Iowa), mouse monoclonal antibody to cat HNK-1/N-CAM, which
cross-reacts with the mouse homologue (VC1.1, Sigma), and mouse monoclonal antibody to
human neurone-speciﬁc class III β-tubulin isotype, which cross-reacts with the mouse homologue
(TU-20, provided by Pavel Dráber, Institute of Molecular Genetics, Prague, Czech Republic).
Antibodies to cyclin D1 (sc-450), CDK4 (sc-260), and cyclin A (sc-751) were from Santa Cruz
Biotechnology and antibody to CDK6 (Ab4) was from Neomarkers. Cells were ﬁxed for 30 min
on ice in ethanol/acetic acid (95% ethanol, 1% acetic acid, for differentiation markers) or in 4%
paraformaldehyde (for cell cycle regulators), then samples were stepwise rehydrated, quenched
with 1% bovine serum albumin in PBS for 1 h at room temperature, incubated with the appropriate
primary antibody (overnight at 4 °C) and FITC-conjugated secondary (1 h at room temperature)
antibodies, and mounted using Mowiol (Sigma). Cells were observed either under an Olympus
BX-60 epiﬂuorescence microscope (Olympus, Prague, Czech Republic) or were scanned using
an Olympus Fluoview 5000 confocal laser scanning microscope.
Statistics
Data were expressed as means ± standard deviations and were analysed using Student’s t-test or
by one-way analysis of variance (anova) followed by the Tukey’s range test (Fig. 2c). A P value
of less than 0.05 was considered to be signiﬁcant.
RESULTS
Characterization of the experimental model
P19 EC cells were differentiated according to two RA-based differentiation protocols (Fig. 1a,
schematic). Cells growing in serum-containing medium or in serum-free ITS medium were ﬁrst
treated with RA for 48 h. Then, they were cultured in the respective media without RA for another
48 h, thus establishing two cell groups further referred to as SR (serum + RA) and IR (ITS + RA)
cells, respectively. It was typical for SR cells to form monolayers of ﬂat cells (Fig. 1b), to express
markers of extraembryonal endoderm such as TROMA-1 (Fig. 1c,d), and to lack markers of
undifferentiated and/or neural cells (Fig. 1c and not shown). In contrast, IR cells adopted neural
morphology (Fig. 1b) and started to express neural markers, for example neural speciﬁc class
III β-tubulin or N-CAM (Fig. 1c,d), while lacking both the endodermal marker TROMA-1 and
the marker of undifferentiated cells Oct-4 (Fig. 1c,d). Control cells were cultured for 96 h in
serum-containing medium (undifferentiated P19 EC cells, further referred to as S cells). Control
cells at 48 h (S48) were fully proliferative and undifferentiated (as repeatedly judged by Oct-4
expression) and thus represent the basic control. More detailed characterization of the outcomes
of SR and IR differentiation protocols has been provided previously (Pachernik et al. 2005).
Cell population growth and cell cycle characteristics
Because population growth- and differentiation-related metabolisms of cell cycle regulators
were to be addressed in this study, it was necessary to ﬁrst deﬁne cell population growth and cell
cycle characteristics of differentiating P19 cells. As determined by both total protein (Fig. 2a)
and total cell number (Fig. 2b), treatment with RA resulted in population growth retardation,Cyclin D/CDK complexes in differentiation 881
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Figure 2. Cell population growth and cell cycle properties. Cells were cultured according to protocols outlined in
Fig. 1a, and at 48 and 96 h of culture population growth and cell cycle properties were determined. Total protein per
dish (a) and total number of cells per dish (b) were quantiﬁed and used as a measure of cell population growth. Mean
and standard deviations from three independent replicates are shown. (S cells – full square; SR cells – open square; IR
cells – open circle). (c) Percentage of cells in individual cell cycle phases was determined by ﬂow cytometry
(mean ± SD, n = 6). (d) Cells were labelled with BrdU for metabolic studies and subsequently they were stained with
propidium iodide and FITC-conjugated anti-BrdU antibody; then, they were scored by ﬂow cytometry. The percentage
of BrdU positive cells indicated as the mean ± SD from three independent replicates is shown. (e) Cleavage of PARP
and lamin B was determined by Western blotting (full arrowheads – full length protein; open arrowheads – cleaved
fragment). (f) Proportion of cells at sub-G0/G1 population (mean ± SD, n = 3), which corresponds to apoptotic cells,
was determined by FACS. ***P < 0.001.882 V . Bryja et al.
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which was more pronounced in IR cells. Distribution of cells in G1, S and G2 phases was then
determined for all three culture protocols, by ﬂow cytometry (Fig. 2c). A signiﬁcant decrease in
numbers of cells in S phase took place after induction of differentiation (S48 versus SR96/IR96;
P < 0.001, One-way anova) and also with increased cell density (S48 versus S96; P < 0.05).
Flowcytometric counting of BrdU-pulse-labelled cells (Fig. 2d) showed that 60–70% of S48
control cells incorporated BrdU into their DNA, whereas at the 96 h time point only, around
10% of cells retained BrdU in S96, SR and IR. Clearly, increased cell density and RA-induced
differentiation both caused inhibition of DNA synthesis under our culture conditions. A high
proportion of S96 cells in S phase suggests that a density-dependent slowdown of DNA synthesis
and subsequent S phase arrest was a major mechanism responsible for reduction in proliferation
in undifferentiated P19 EC cells, as was shown recently for mouse ES cells (Jirmanova et al.
2005; Andäng et al. 2008). In contrast, both SR and IR cells accumulated in G1 phase at the
expense of in S phase, suggesting that G1/S transition was affected. Importantly, SR and IR cells were
indistinguishable from each other based on cell cycle distribution/proliferation characteristics.
As an additional parameter, we analysed the level of apoptosis using three apoptotic markers –
cleavage of PARP, cleavage of lamin B, and proportion of cells in sub-G0/G1. We could detect
cleavage of caspase substrates PARP and lamin B clearly (Fig. 2e) and increased number of cells
in sub-G0/G1 population in S96, SR96 and IR96 cells, as determined by ﬂuorescence-activated
cell sorter (FACS) analysis (Fig. 2f). Interestingly, PARP was cleaved mainly in S96 and IR96 cells,
whereas lamin B was cleaved mainly in SR96 and IR96 cells. PARP and lamin B are substrates
of distinct caspases (Slee et al. 2001), and different patterns of their cleavage suggest that the
mechanisms of apoptotic activation in S96, SR96 and IR96 cells may differ.
Structure and kinase activity of cyclin A/E-CDK2-p27 complexes during differentiation
CDK2 and its regulatory partners, cyclins A and E, and appropriate CKIs are major drivers of
G1/S transition and S-phase progression. We have analysed levels, mutual interactions, and kinase
activities of cyclins A and E, CDK2, and p27 (the only CKI showing detectable levels in P19
cells; Fig. 3). Cyclin E-associated kinase activity dropped both by induction of differentiation
(SR/IR) and with increasing cell density (S96), which is likely due to a combination of increased
binding of p27 and down-regulation of cyclin E. Cyclin A showed a more complex pattern, which
was characterized by decreased cyclin A-associated kinase activity and increased association
with p27 in differentiated cells (SR96/IR96). Interestingly, increased density of S96 cells resulted
in increased level of cyclin A and cyclin A/CDK2 activity, despite higher association with p27.
Because S96 cells did not incorporate BrdU (Fig. 2c), it is possible that cyclin A/CDK2 complex
had an additional function in S96 cells. In all cultures other then S96, however, activity of CDK2
correlates well with binding of its activating and inhibiting partners and matches observed
growth characteristics of the cells (Fig. 2).
Levels of D-type cyclins during cell differentiation
Along with CDK2, CDK4 and CDK6 with their partner D-type cyclins were involved in regulation
of G1/S transition. As shown in Fig. 4a, only cyclin D1 was expressed in signiﬁcant levels in
fully proliferating undifferentiated P19 cells (S48), although a minute amount of cyclin D2 was
also present. When differentiation was induced, both cyclin D2 and cyclin D3 became up-regulated
(Fig. 4a). Prolonged culture lead also to up-regulation of cyclin D3 in undifferentiated S96 cells,
suggesting that not only RA treatment but also other signals (most likely increased cell density),
may induce expression of D-type cyclins in P19 cells. Previously, we have shown that in differentiated
cells, D-type cyclins accumulate due to stabilization by binding partners and not due to changes
in their transcription (Bryja et al. 2004a). To resolve whether or not the changes in levels ofCyclin D/CDK complexes in differentiation 883
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were used to immunoprecipitate cyclin A, cyclin E, CDK2 and p27. In cyclin- and CDK2-immunoprecipitates kinase
activities towards histone H1 were determined by autoradiography and three independent replicates were quantiﬁed by
densitometry. Graphs represent means ± SDs of autoradiographic signal normalized to S samples at 48 h. Quantity of
p27 in cyclin A, cyclin E and CDK2 immunoprecipitates and the amount of cyclin A in CDK2 and p27 immunoprecipitates
were determined by Western blotting. Total amount of cyclin A, cyclin E, CDK2 and p27 as determined by Western
blotting and total protein level as determined by amidoblack staining are also presented. Data are representative of at least
three independent replicates.
Figure  3. Analysis of cyclin A/E–CDK2–
p27 complexes. Cells were cultured according
to protocols outlined in Fig. 1a, and cell lysates884 V . Bryja et al.
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D-type cyclins and p27 were due to increased levels of transcripts, we have determined the
mRNA levels by real-time quantitative RT-PCR (Fig. 4b). Amounts of transcripts coding for
cyclins D and p27 matched well changes in the respective protein levels, suggesting that D-type
cyclins and p27 were regulated during differentiation primarily via transcription mechanisms.
Only cyclin D1 showed more complex regulation with low quantities of protein in differentiated
cells despite high level of its mRNA. Importantly, based on the obvious lack of correlation
between levels of mRNA for individual D-type cyclins and cell growth characteristics, we
Figure 4. Expression of D-type cyclins. Cells were cultured according to protocols outlined in Fig. 1a. (a) Amounts
of cyclins D1, D2 and D3 in protein samples were quantiﬁed by Western blotting. Data are representative of four
independent replicates. (b) Expression of mRNA coding for p27, cyclins D1, D2 and D3 was quantiﬁed using
quantitative real-time RT-PCR. Data represent means ± SDs of four independent replicates.Cyclin D/CDK complexes in differentiation 885
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hypothesize that in differentiating P19 cells these cyclins play role(s) other than regulation of
cell cycle progression.
Activity and binding partners of CDK4 and CDK6 during differentiation
In the next step, we determined to what extent changes in levels of D-type cyclins translated into
composition and activity of complexes involving CDK4 and CDK6. Both CDK4 and CDK6
proteins were present in P19 cells with their total quantities not changing during differentiation
(Fig. 5a,b). Interestingly, there were major differences among D-type cyclins in their association
with CDK4. While in fully proliferating undifferentiated P19 cells (S48) cyclin D1 was the only
cyclin bound to CDK4, signiﬁcant physical interaction of CDK4 with cyclins D2 and D3 was
observed in cells induced to differentiate by RA. Speciﬁcally, the following cyclins had undergone
the most prominent increase in binding to CDK4: (i) cyclins D2 and D3 in undifferentiated S
cells, (ii) cyclin D3 in endodermal (SR) cells, and (iii) cyclins D1 and D2 in neural (IR) cells.
Despite our inability to detect measurable CDK6-associated kinase activity, there were clear
partnerships of this molecule with some D-type cyclins and also with p27 (Fig. 5b). Interestingly,
binding of D-type cyclins to CDK6 was completely different from their association to CDK4. In
undifferentiated, proliferating S48 cells, CDK6 associated with only small amounts of cyclin D2
and p27. In contrast, growth-arrested S96 cells were characterized by high levels of cyclins D2
Figure  5. Analysis of cyclin D–CDK4/6–p27 complexes. Cells were cultured according to protocols outlined in
Fig. 1a, and cell lysates were analysed. (A) In CDK4 immunoprecipitates, kinase activities to GST-pRb were determined
by autoradiography and three independent replicates were quantiﬁed by densitometry. Graphs represent means ± SDs
of autoradiographic signals normalized to S-phase samples at 48 h. Amounts of cyclin D1, cyclin D2, cyclin D3 and
p27 in CDK4 immunoprecipitates, as well as total level of CDK4, were determined by Western blotting. (b) Quantities
of cyclin D2, cyclin D3 and p27 in CDK6 immunoprecipitates, as well as total amount of CDK6, were determined by
Western blotting. (c) Samples were immunoprecipitated by p27-speciﬁc antibody and levels of cyclin D1, cyclin D2
and cyclin D3 bound to p27 were determined by Western blotting. Data in (a–c) are representative of at least three
independent replicates.886 V . Bryja et al.
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and D3 interacting with CDK6; however, such interactions were much less pronounced in
cells differentiating into endodermal (SR) and neural (IR) lineages. Strong physical interaction
between CDK6 and p27 was detected in S96 and SR96 cells. No interaction of cyclin D1 with
CDK6 was observed under any condition. To complement the analysis, we also determined the
portions of D-type cyclins that physically interacted with p27. Cyclin D1 bound to p27 in IR96
cells (Fig. 5), cyclin D2 bound to p27 in a pattern corresponding well to the total amount of cyclin
D2, and cyclin D3 bound to p27, mainly in dense, serum-containing cultures (S96 and SR96
cells). Taking all these data together, CDK4 associated with p27 and D-type cyclin partners
mainly during differentiation of P19 cells, although such interactions were clearly speciﬁc for
individual D-type cyclins. In contrast, complexes involving CDK6 and its partners developed
predominantly in cells that were approaching conﬂuence (S96 and SR96). Importantly, although
D-type cyclins associated with CDK4 during differentiation, neither CDK4-associated kinase
activity nor cell population growth was stimulated in differentiating cells.
Localization of p27 and D-type cyclins in differentiating cells
Cyclin-CDK complexes phosphorylate their targets, which then further regulate cell cycle
progression. The majority of these events occur in nucleus. In this study, we have shown that
changes in levels of D-type cyclins were not linked to cell cycle characteristics of differentiating
P19 cells. Therefore, we hypothesized that speciﬁc subcellular localization of certain members
of cell cycle-regulating machinery may be responsible for absence of the expected link. To
address this issue, we employed immunocytochemistry to visualize subcellular localization of
cyclin A, cyclin D1, CDK4 and CDK6 in situ in S48 (undifferentiated), SR96 and IR96 cells.
As shown in Fig. 6a, cyclin A was predominantly nuclear under all conditions. In contrast,
although cyclin D1, CDK4 and CDK6 were mostly nuclear in undifferentiated cells (S48), they
all appeared in cytoplasm following differentiation to endodermal (SR96) and/or neural (IR96)
lineages. Interestingly, in neural IR cells, both CDK4 and CDK6 were heavily associated with
neurite outgrowths. To complement immunohistochemical analysis, cell lysates of differentiated
cells were separated into nuclear and cytoplasmic fractions, and the efﬁciency of this separation
process was conﬁrmed by including analysis of cytoplasmic α-tubulin, a component of nuclear
membrane lamin B, and chromating binding protein HP1α. As shown in Fig. 6b, all D-type
cyclins and p27 were predominantly cytoplasmic. These localization data ﬁt the general scenario
well, in which the major cell cycle driving force in pluripotent embryonic cells is represented
by cyclin A–CDK2–p27 complexes, whereas cytoplasmic CDK4/6, in association with D-type
cyclins and p27, predominantly have other function in differentiating cells.
Dynamics of expression, binding and localization of cell cycle regulators in mouse ES cells
To further address the signiﬁcance of the behaviour of cell cycle regulators observed here in P19
cells, untransformed pluripotent mouse embryonic stem cells (mESCs) were also subjected to similar
analyses. We were not successful in transferring the neural differentiation protocol (IR) to mESCs,
mainly because high cell death was associated with given treatments to mESCs (not shown). Yet,
the endodermal differentiation protocol (SR) proved to be fully applicable to mESCs and produced
relevant data. As shown in Fig. 7a, expression patterns of D-type cyclins and p27 did not differ from
those observed in differentiating P19 cells. Importantly, endodermal differentiation was accompanied
by remodelling of protein complexes involving CDK4 (Fig. 7b). In undifferentiated mESCs (S48),
CDK4 predominantly bound cyclin D1, which was replaced during progressing differentiation
by cyclins D2 and D3 together with p27. These expression and interaction patterns closely resemble
behaviour of the cell cycle regulators in P19 cells, differentiating under identical conditions.
Interestingly, similarly to P19 cells, cyclin D/CDK4/p27 complexes in differentiating mESCsCyclin D/CDK complexes in differentiation 887
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were likely to be localized in the cytoplasm as indicated by cytoplasmic localization of individual
D-type cyclins, CDK4 and p27 (Fig. 7c). Taken together, metabolism of cell cycle regulators,
although here determined in detail primarily using P19 EC cells, is very likely characteristic for
pluripotent cells of embryonic origin rather than only for transformed EC cells.
Figure 6. Intracellular localization of regulators of G1/S transition. (a) Subcellular localization of cyclin A, cyclin
D1, CDK4 and CDK6 as determined by immunocytochemistry (green) in undifferentiated cells (S48) and in cells
differentiated into endodermal (SR96) and neural (IR96) lineages. Nuclei were visualized by counterstaining with
propidium iodide. All scans have been acquired using identical settings of the confocal microscope. (b) Cells
were grown according to protocols outlined in Fig. 1a, and at 96 h of culture cell lysates were separated into nuclear
and cytoplasmic fractions. Amounts of p27, D-type cyclins, CDK4 and CDK6 in nuclear (N) and cytoplasmic (c) fractions
were quantiﬁed by Western blotting. To demonstrate efﬁciency of separation, levels of control proteins localized
predominantly to cytoplasm (α-tubulin) and nucleus (lamin B, HP1α) were also analysed by Western blotting.888 V . Bryja et al.
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DISCUSSION
Cell type- and tissue-speciﬁc expressions of cyclins and CKIs during development and in the adult
are believed to not only underlie differences in cell cycling parameters but also to participate in
promoting differentiation and/or maintenance of the differentiated state. The ultimate aim of this
study was to investigate the link between metabolism of key members of the cell cycle-regulating
machinery and lineage determination, in differentiating pluripotent cells of embryonic origin. To
do so, two differentiation protocols were implemented, which produced cells of two different
phenotypes: endodermal (positive for TROMA-1) and neural (positive for neural speciﬁc class
III β-tubulin). Analyses described here have led to two major revelations. First, the cell cycle
characteristics of P19 cells and their differentiated progeny correlated well with activity of
Figure 7. Analysis of cyclin D–CDK4/6–p27 complexes in mouse embryonic stem cells (mESCs). mESCs (S48)
were cultured according to SR protocol outlined in Fig. 1a for 48 (SR48) and 96 h (SR96). (a) Expression of CDK2,
CDK4, cyclin D1, cyclin D2, cyclin D3 and p27 were determined by Western blotting; lamin B was used as a loading
control. (b) Cell lysates were subjected to immunoprecipitation using anti-CDK4 antibody (IP CDK4) and amount of
cyclins D1, D2, D3, and p27 bound to CDK4 in immunoprecipitates was analysed by Western blotting. (c) Cell lysates
were subjected to nucleo/cytoplasmic separation and levels of CDK4, cyclin D2, cyclin D3 and p27 in nuclear (N) and
cytoplasmic (c) fractions were analysed by Western blotting. Nuclear proteins lamin B and HP1α were used as loading
and separation efﬁciency controls. Data in (a–c) are representative of three independent replicates.Cyclin D/CDK complexes in differentiation 889
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CDK2. Moreover, activity of CDK2 correlated with cyclin A- and cyclin E-associated kinase
activity, as well as with association with CDK inhibitor p27. Second, amounts of D-type cyclins
and their physical interactions with CDK4 were elevated in the conditions which did not support
proliferation. Moreover, complexes of D-type cyclins with CDK4/6, which are distinct depending
on differentiation program, were localized predominantly in cytoplasm, contrasting with the
nuclear localization of complexes involving cyclin A and CDK2. Taken together, these data
strongly suggest that although cyclin A/E–CDK2–p27 complex regulates progression of the cell
cycle in differentiating P19 cells, major role of cyclin D–CDK4 complexes in these embryonic
cells differed from the regulation of entry into S phase. It should, however, be noted that any
pro-differentiation function of cyclin D–CDK4/6–p27 complexes was not in conﬂict with their
function in regulation of G1/S transition. It is possible that subcellular localization represents a
mechanism of how these independent functions were realized and regulated.
It has been shown that although cells are able to proliferate in the absence of both CDK4/6
kinases (Malumbres et al. 2004) and D-type cyclins (Kozar et al. 2004), differentiation in D-cyclin-
null embryos is often affected (Fantl et al. 1995; Sicinski et al. 1995; Chellappan et al. 1998;
Huard et al. 1999; Ciemerych et al. 2002). Our screen identiﬁes cyclin D2, cyclin D3 and p27
as the molecules that become expressed and stay elevated when EC and mESC cells are induced
to differentiate. Instead, bimodal expression was typical for cyclin D1 (with this cyclin being
high in undifferentiated cells), and after transient decrease being up-regulated again, but only in
the neural lineage. Obviously, the coordinated increase of p27 and cyclin D2 and/or D3 during
differentiation was not an uncommon phenomenon, as it has been widely described using other
differentiation models (Savatier et al. 1995; Gill et al. 1998; Baldassarre et al. 1999; Li et al.
1999; Watanabe et al. 1999; Baldassarre et al. 2000; Glozak et al. 2001; Preclikova et al. 2002;
Bryja et al. 2004b; Bryja et al. 2005). In the present study, however, detailed analysis of the
dynamics of a composition of cyclin D–CDK4/6–p27 complex unravelled important differences,
not only in a utilization of individual D-type cyclins but also in the roles of CDK4 and CDK6,
respectively. As indicated in the schematic diagram (Fig. 8a), undifferentiated, exponentially
growing cells (S48) mostly contained cyclin D1 associated with CDK4 and a low level of cyclin
D2 complexed with CDK6. Although p27 was detected, the level of this regulator was very low
in undifferentiated P19 cells. In 2 further days, when cells cultured under non-differentiating
conditions reached conﬂuence (S96), p27, cyclin D2 and cyclin D3 were induced and they
bound mainly to CDK6 and to CDK4. Simultaneously, expression of cyclin D1 became reduced
and its binding to CDK4 was abolished.
In contrast to the molecular pattern typical for cultures of undifferentiated cells (Fig. 8a),
completely different components were utilized by the cells induced differentiation, either into
TROMA-I-positive cells resembling extra-embryonic endoderm (SR96; Fig. 8b) or into neural
cells expressing neural speciﬁc class III β-tubulin (IR96; Fig. 8c). During endodermal differen-
tiation cyclin D2, cyclin D3 and p27 were also induced but they associated mainly with CDK4
(and only to a small extent with CDK6), thus forming inactive, predominantly cytoplasmic cyclin
D2/D3–CDK4–p27 complexes, which replaced nuclear cyclin D1–CDK4 complexes contained
in undifferentiated P19 cells. Differentiation towards neural lineage was also associated with
up-regulation of D-type cyclins and p27, which then bound to CDK4 (and not CDK6). Notably,
cyclins D1 and D2 were dominant in neural differentiation, instead of cyclins D2 and D3, typical
of endodermal differentiation. Cyclin D2 is expressed throughout embryonic and adult brain
(Ross & Riskin 1994; Ross et al. 1996) and its speciﬁc role in neurodifferentiation has been
documented in several lines of evidence. Cyclin D2-deﬁcient mice display defects in architecture
of the cerebellum, due to inappropriate proliferation of granule cell precursors and due to defects
in differentiation of granule and stellate interneurones (Huard et al. 1999). Moreover, additional890 V . Bryja et al.
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ablation of cyclin D1 further ampliﬁes the defects observed in cyclin D2-deﬁcient mice – the
cyclin D1–/–D2–/– mouse has severely impaired development of the cerebellum which develops
only in a rudimentary form (Ciemerych et al. 2002). Cooperation of cyclins D1 and D2 thus
correspond well with their speciﬁc up-regulation observed here in neural IR cells.
Two major conclusions can be drawn from the above analysis: (i) distinct D-type cyclins are
utilized in neural and endodermal differentiation; (ii) CDK4 is a major partner of D-type cyclins
and p27 in differentiated cells, whereas CDK6 is bound to D-type cyclins and p27 in undiffer-
entiated cells at higher densities. CDK4 and CDK6 are considered to be largely redundant in
their ability to bind D-type cyclins and to phosphorylate target proteins, as well as in their
biological function (for review, see Ekholm & Reed 2000). Distinct roles for CDK4 and CDK6
in cells of embryonic origin are suggested in our study, by differing metabolism of CDK4-
and CDK6-containing complexes. We have shown previously that similar rapid and complete
re-structuring of cyclin D–CDK4/6 complexes from cyclin D2/D3–CDK6 to cyclin D3–CDK4–
p21/p27 accompanies ﬁbroblast growth factor 2 (FGF2)-induced inhibition of cell proliferation
in rat chondrosarcoma chondrocytes (Krejci et al. 2004). Furthermore, cyclin D3–CDK6 and
cyclin D1–CDK4 complexes, which are typical for undifferentiated mESCs (Faast et al. 2004;
Cajánek unpublished), become rebuilt into cyclin D3–CDK4–p27 complexes (Savatier et al.
1995; Bryja et al. 2004b) upon entry into the differentiation pathway. Unfortunately, functional
signiﬁcance of such dramatic molecular changes occurring to CDK4 and CDK6 is as yet largely
unexplored, with only some distinct properties of CDK4 and CDK6 being recently found with
respect to (i) substrate speciﬁcity (Takaki et al. 2005); (ii) sensitivity to the CKI inhibitors of INK4
family (Lin et al. 2001; Faast et al. 2004); and (iii) utilization of individual post-translational
variants of p27 and subsequently ability to sequester p27 from CDK2. Although our experiments
could not provide thorough functional analysis, they are still important by not only presenting
further evidence for unequal roles of CDK4 and CDK6, but also primarily by pointing to CDK4,
CDK6, and their partners concerning molecules that are involved in driving differentiation proc-
esses which take place in early development.
Figure 8. Shufﬂing of cyclin D–CDK4/6–p27 complexes in P19 EC cells. In exponentially growing P19 EC cells,
kinase-active cyclin D1–CDK4 was a predominant complex but low amounts of cyclin D2–CDK6–p27 were also
present. (a) When cells became conﬂuent, cyclin D1 was down-regulated, and increased cyclins D2 and D3 together with
p27 bound to CDK6 and to CDK4. (b) During endodermal differentiation, levels of cyclins D2 and D3 were increased
and they formed kinase-inactive complexes with p27 and CDK4. (c) During differentiation into neural lineage, p27 and
CDK4 bound to cyclins D1 and D2 and formed kinase-inactive cyclin D1/2–CDK4–p27 complexes.Cyclin D/CDK complexes in differentiation 891
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Here, we have demonstrated that individual D-type cyclins were differently utilized during lineage
speciﬁcation, with cyclins D1 and D2 (but not cyclin D3) being typical for differentiation towards
the neural lineage. Similarly, substrate speciﬁcities of CDK4 and CDK6, and also CDK4 complexed
to different D-type cyclins, may differ in substrate speciﬁcity as clearly demonstrated by Paternot
et al. (2006). Cyclins D1 and D2 are crucial for neural development in mouse (Ciemerych et al.
2002) and cooperation of cyclins D1 and D2 in mouse development thus correspond well with
their speciﬁc up-regulation observed here in neural lineage (IR) cells. Although the precise
molecular mechanism of cyclin D1 and/or cyclin D2 action in neurodifferentiation is not yet
known, recent data suggest that both these cyclins may be involved in regulation of apoptosis
in neural cells. Cyclin D2 has been shown to mediate anti-apoptotic effects on cerebellar
neuroblasts (Poguet et al. 2003) and cytoplasmic localization of cyclin D1 is required to protect
differentiating neurones from apoptosis (Sumrejkanchanakij et al. 2003). We have previously
demonstrated similar anti-apoptotic functions for cyclin D3 in complex with p27 in mESCs,
differentiating into extra-embryonic endoderm (SR cells) (Bryja et al. 2004b). We suggest that
neural IR cells expressing high levels of cyclins D1 and D2 localized in the cytoplasm, bound
to but not activating CDK4, provide an in vitro system to investigate the role of D-type cyclins
in neural differentiation in more detail.
In summary, our data provide evidence that depending on cell fate, diverse cyclin D–CDK4/
6–p27 complexes are formed and are utilized distinctly by pluripotent embryonic cells. Whereas
CDK4 is a major partner of cytoplasmic D-type cyclins and p27 in differentiating cells (associated
with cyclins D1 and D2 in neuroectodermal cells and with cyclins D2 and D3 in endodermal
cells), CDK6 binds D-type cyclins and p27 when cells are at high cell density. Our data suggest
that individual D-type cyclins as well as CDK4 and CDK6 have sub-type speciﬁc and cell cycle
regulation-independent functions utilized during embryonic development and differentiation of
stem cells. From a practical point of view, this study provides a well-characterized experimental
model to address biological processes whose understanding is required for safe use of human
ES cells in cell therapies.
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